Mayo Clinic Cancer Center finds possible genetic link to pancreatic cancer
Study shows cystic fibrosis gene mutation a risk factor for young-onset disease
Mayo Clinic researchers have found the risk of developing pancreatic cancer at a young age (under 60) to be twice as high for people who carry a mutation of the gene that causes cystic fibrosis, compared to noncarriers. Results of a pilot and follow-up study were reported Oct. 14, 2005, online in the journal Gut.
Pancreatic cancer kills over 32,000 people in the United States each year Twenty percent are under age 60. "Being able to screen for a genetic mutation that points to a higher risk will enable us to intervene earlier," says Robert McWilliams, M.D., Mayo Clinic oncologist and lead author of the study. "Early screening is one step in the process to developing ways to prevent or cure this deadly disease."
Nearly all patients who develop pancreatic cancer will succumb to the disease. A genetic marker that helps physicians find individuals most at risk to develop the cancer also will help find it early enough to perform effective surgery. Individuals who carry the cystic fibrosis gene mutation are at increased risk for pancreatitis -- inflammation of the pancreas. Chronic pancreatitis has been proven to increase the risk of pancreatic cancer 26-fold, which led Mayo Clinic researchers to the hypothesis that mutations in the gene that carries cystic fibrosis may be directly linked to a higher risk for pancreatic cancer.
From October 2000 to April 2004, pancreatic cancer patients seen at Mayo Clinic were recruited for the study -- 75 percent of all new patients registered. The pilot study reviewed 33 patients from 41 to 81 years old, with seven having a diagnosis of pancreatitis at least one year prior to cancer diagnosis. Of the 33, a mutation was found in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in two patients, both younger than 60. A follow-up study was designed to test all the young-onset cases in the registry, resulting in a study group of 166 young-onset pancreatic cancer patients. This study showed that mutations in the CFTR gene were present in twice as many young pancreatic cancer patients than in the comparison group, which consisted of all patients tested for CFTR at Mayo Clinic from November 2003 to May 2004.
Further study is needed, and Dr. McWilliams cautions that the overall risk to carriers of cystic fibrosis is still small. However, he and his colleagues say this is a step towards greater understanding of who is at risk for developing pancreatic cancer at a young age. "We are excited about the finding," says Dr. McWilliams, "And we have an additional study underway with more patients to confirm the finding for young patients as well as look at implications for those over age 60."
Other Mayo Clinic researchers involved with this study include: W. Edward Highsmith Jr., Ph.D.; Kari Rabe; Mariza de Andrade, Ph.D.; Larry Tordsen; Leonard Holtegaard; and Gloria Petersen, Ph.D.
Elizabeth Zimmermann | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
Germany counts high-precision manufacturing processes among its advantages as a location. It’s not just the aerospace and automotive industries that require almost waste-free, high-precision manufacturing to provide an efficient way of testing the shape and orientation tolerances of products. Since current inline measurement technology not yet provides the required accuracy, the Fraunhofer Institute for Laser Technology ILT is collaborating with four renowned industry partners in the INSPIRE project to develop inline sensors with a new accuracy class. Funded by the German Federal Ministry of Education and Research (BMBF), the project is scheduled to run until the end of 2019.
New Manufacturing Technologies for New Products